Preview

Current Pediatrics

Advanced search

CLINICAL FEATURES AND CHARACTERISTICS OF VEGETATIVE STATUS IN CHILDREN AND ADOLESCENTS WITH CONNECTIVE TISSUE DYSPLASIA

Abstract

950 schoolchildren in Omsk were observed for the purpose of detection of signs of connective tissue dysplasia (CTD). An intensity of symptoms of CDT, vegetative dysfunction, psycho emotional status were estimated with following correction of these disorders with magnesium orotate (marnerot). The symptoms of CTD were detected in more then a half of children and adoles cents with maximal detectability in age of 13–17 years old. An influence of sympathetic system on vegetative status was registered in children and adolescents. Typical signs of it were discoordinated vegetative regulation of respiratory and cardio vascular systems, disorder of psycho emotional status (instability in uneasiness factor, factor of instability of choice, factor of capacity of work). Treatment with magnesium orotate in children and adolescents with CDT was followed by positive changes of state of health, decrease of symptoms of vegetative disbalance, normalization of psycho emotional status, mainly due to restoration of capacity to work.
Key words: children, adolescents, connective tissue dysplasia, vegetative dysfunction, magnesium orotate.

About the Authors

I.A. Viktorova
Omsk State Medical Academy
Russian Federation


D.S. Kiseliova
Omsk State Medical Academy
Russian Federation



I.G. Kalitskaya
A.N. Kabanov Omsk City Clinical Hospital № 1
Russian Federation


L.M. Korableva
A.N. Kabanov Omsk City Clinical Hospital № 1
Russian Federation


S.G. Suvorova
A.N. Kabanov Omsk City Clinical Hospital № 1
Russian Federation


References

1. Куликов А.М., Медведев В.П. Роль семейного врача в охране здоровья подростка. Дисплазия соединительной ткани у подростков и ее распознавание. Российский семейный врач. 2000; 4: 37–51.

2. Нечаева Г.И., Викторова И.А. Дисплазия соединительной ткани: терминология, диагностика, тактика ведения пациентов. Омск: БЛАНКОМ. 2007. 188 с.

3. Степура О.Б., Мельник О.О., Шехтер А.Б. и др. Результаты применения магниевой соли оротовой кислоты «Магнерот» при лечении больных с идиопатическим пролапсом митрального клапана. Российские медицинские вести. 1999; 4 (2): 64–69.

4. Kitlinski M., Konduracka Е., Piwowarska W. Еvaluation of magnesium cation levels in serum of patients with mitral valve prolapse syndrome. Folia Med. Сracov. 2000; 47: 17–24.

5. Lichodziejewska B., Klos J., Rezler J. et al. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am. J. Cardiol. 1997; 79 (6): 768–772.

6. Заболевания вегетативной нервной системы. Руководство для врачей. Под ред. А.М. Вейна. М.: Медицина. 1991. 624 с.

7. Гофман О.М. Дифференциально-диагностическое значение малых аномалий развития в оценке состояния здоровья детей. Автореф. дис. ... канд. мед. наук. М. 1987. 17 с.

8. Беленький А.Г. Синдром гипермобильности суставов: номенклатура, клинические проявления и лечение. Consilium Medicum. 2001; 3 (9): 421–424.


Review

For citations:


Viktorova I., Kiseliova D., Kalitskaya I., Korableva L., Suvorova S. CLINICAL FEATURES AND CHARACTERISTICS OF VEGETATIVE STATUS IN CHILDREN AND ADOLESCENTS WITH CONNECTIVE TISSUE DYSPLASIA. Current Pediatrics. 2008;7(5):27-33.

Views: 701


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)